XML 118 R99.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-Based Compensation (Narrative) (Details)
$ / shares in Units, shares in Thousands
3 Months Ended 12 Months Ended
Oct. 04, 2022
USD ($)
shares
Dec. 01, 2021
USD ($)
milestone
shares
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2023
USD ($)
tranche
$ / shares
shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting period       3 years    
Granted (in shares) | shares     25,235 25,235    
Stock based compensation expense reversal       $ 18,392,000    
Basic (in dollars per share) | $ / shares       $ 0.14    
Diluted (in dollars per share) | $ / shares       $ 0.14    
Stock-based compensation expense       $ 23,504,000 $ 42,415,000 $ 55,153,000
Stock options exercisable (in shares) | shares     0 0 0  
Unrecognized stock-based compensation expense     $ 0 $ 0 $ 0  
Share-Based Payment Arrangement, Tranche One            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting percentage       33.33%    
Share-Based Payment Arrangement, Tranche Two            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting percentage       33.33%    
Share-Based Payment Arrangement, Tranche Three            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting percentage       33.33%    
Volumetric            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Additional payments     $ 355,000,000 $ 355,000,000    
Number of milestones | milestone   7        
Earnout payment milestone       65,000,000    
Aggregate grant date fair value of outstanding and unvested         4,536,000  
Volumetric Biotechnologies, Inc.            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Additional payments   $ 355,000       355,000,000
Number of milestones | milestone   7        
Issuance of shares (in shares) | shares   720        
Stock-based compensation expense       (8,640,000) 7,959,000 683,000
Dp polar GmbH            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Additional payments $ 2,229,000          
Issuance of shares (in shares) | shares 250          
Stock-based compensation expense       $ 1,015,000 268,000 0
Systemic Bio Phantom Unit Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, number (in shares) | shares     596 596    
Phantom Share Units (PSUs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting period       1 year 10 months 24 days    
Unrecognized stock-based compensation expense     $ 41,161,000 $ 41,161,000    
Phantom Share Units (PSUs) | Systemic Bio Phantom Unit Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting period       4 years    
Granted (in shares) | shares       597    
Deferred compensation       $ 544,000    
Phantom Share Units (PSUs) | Minimum | Systemic Bio Phantom Unit Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unrecognized stock-based compensation expense, period for recognize     40 months 15 days      
Phantom Share Units (PSUs) | Maximum | Systemic Bio Phantom Unit Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unrecognized stock-based compensation expense, period for recognize     48 months      
Performance Shares            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of non-financial milestones | milestone   4        
Incentive Awards            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock-based compensation expense       $ 0 $ 4,030,000 $ 22,057,000
Restricted Stock - Market Conditions            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares awarded (in shares) | shares       1,106    
Restricted Stock - Performance Measures            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares awarded (in shares) | shares       966    
Stock Options and Restricted Stock Awards | 2015 Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of tranches | tranche       2    
Trading price for stock award, tranche one (in dollars per share) | $ / shares       $ 30    
Trading price for stock award, tranche two (in dollars per share) | $ / shares       $ 40    
Stock award tranche granting period       90 days